Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Politics Reporter.
Press releases published on June 11, 2025
ROSEN, A LEADING LAW FIRM, Encourages Open Lending Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – LPRO
GlobeNewswire
·
June 11, 2025
NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Open Lending Corporation (NASDAQ: LPRO) between February 24, 2022 and March 31, 2025, both dates inclusive (the “Class …
RKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rock Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
June 11, 2025
NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
June 11, 2025
NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
FTRE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fortrea Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
June 11, 2025
NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz …
BRMK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Broadmark Realty Capital Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
June 11, 2025
NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
PEPG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that PepGen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
June 11, 2025
NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
VSTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Vestis Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
June 11, 2025
NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
MEDIA ADVISORY Paris Air Show 2025: Ohio Hosts Leading Aerospace Companies, U.S. Department of Transportation for Panel Discussions and Media Events at Global Industry Conference
GlobeNewswire
·
June 11, 2025
PARIS, France, June 11, 2025 (GLOBE NEWSWIRE) -- Ohio is North America’s premier location when it comes to supporting the global and domestic aerospace, aviation and defense industries. In Ohio, aerospace companies can design, build and fly (in ample …
Attention Long-Term Investors of AppLovin Corporation (NASDAQ: APP); Mercury Systems, Inc. (NASDAQ: MRCY); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Treace Medical Concepts, Inc. (NASDAQ: TMCI) – Grabar Law Office is Investigating Claims on…
GlobeNewswire
·
June 11, 2025
PHILADELPHIA, June 11, 2025 (GLOBE NEWSWIRE) -- AppLovin Corporation (NASDAQ: APP): Grabar Law Office is investigating claims on behalf of shareholders of AppLovin Corporation (NASDAQ: APP). The investigation concerns whether certain officers and directors …
Shareholders who lost money on PepGen Inc. (NASDAQ: PEPG) Should Contact Wolf Haldenstein
GlobeNewswire
·
June 11, 2025
NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- June 11, 2025 - Wolf Haldenstein Adler Freeman …
Iovance’s (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor Lawsuit– Hagens Berman
GlobeNewswire
·
June 11, 2025
SAN FRANCISCO, June 11, 2025 (GLOBE NEWSWIRE) -- A year ago, Bay Area biotech firm Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) was riding high on the promise of its newly approved cell therapy, Amtagvi. Today, the mood has shifted dramatically. On May 16, …
UroGen Pharma Ltd. (URGN) Faces Securities Class Action Amid FDA’s Briefing Document and Subsequent ODAC Vote Against UGN-102– Hagens Berman
GlobeNewswire
·
June 11, 2025
SAN FRANCISCO, June 11, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Cockrell v. UroGen Pharma Ltd. et al., No. 3:25-cv-06088 (D. N.J.) has been filed and seeks to represent investors who purchased or otherwise acquired UroGen …
TRAXXAS ALERT: Bragar Eagel & Squire, P.C. is Investigating Traxxas, L.P. on Behalf of Traxxas Customers and Encourages Consumers to Contact the Firm
GlobeNewswire
·
June 11, 2025
NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel …
Alectra Raises $185,000 for The Princess Margaret Cancer Foundation in annual Ride to Conquer Cancer
GlobeNewswire
·
June 11, 2025
MISSISSAUGA, Ontario, June 11, 2025 (GLOBE NEWSWIRE) -- For the ninth consecutive year, Alectra team members geared up for the Ride to Conquer Cancer, cycling more than 200 kilometres from Toronto to Niagara Falls in support of life-saving cancer research …
Dr. Hazem Afifi Launches Scholarship to Support the Next Generation of Medical Students
GlobeNewswire
·
June 11, 2025
LAS VEGAS, June 11, 2025 (GLOBE NEWSWIRE) -- A new scholarship opportunity is now available to help undergraduate students pursuing careers in medicine achieve their academic and professional goals. The Dr. Hazem Afifi Scholarship for Medical Students has …
Chiesi Group ingår ett globalt licensavtal med Key2Brain AB för utveckling av terapier som passerar blod-hjärnbarriären för behandling av lysosomala upplagringssjukdomar
GlobeNewswire
·
June 11, 2025
Samarbetet kommer att utnyttja Key2Brains teknik för att ta fram enzymersättningsbehandlingar som passerar blod-hjärnbarriären för lysosomala upplagringssjukdomar Avtalet bygger på ett partnerskap som inleddes 2022 och stödjer fortsatt utveckling som drivs …
Chiesi Group sigla un accordo di licenza mondiale con Key2Brain AB per promuovere terapie che attraversano la barriera ematoencefalica per le malattie da accumulo lisosomiale
GlobeNewswire
·
June 11, 2025
La collaborazione sfrutterà la tecnologia di Key2Brain per sviluppare terapie enzimatiche sostitutive in grado di attraversare la barriera ematoencefalica per le malattie da accumulo lisosomiale L'accordo si basa su una partnership avviata nel 2022, a …
Compass Diversified (CODI) Grapples with Financial Irregularities, Slashes Dividend Amid Investor Lawsuit – Hagens Berman
GlobeNewswire
·
June 11, 2025
SAN FRANCISCO, June 11, 2025 (GLOBE NEWSWIRE) -- Shares of Compass Diversified (NYSE: CODI) plunged nearly 15 percent in intraday Wednesday trading, as the private equity firm scrambled to shore up its finances following the discovery of troubling …
NCLA’s King George III Prize Crowns Former SEC Chair Gensler 2024’s Worst Civil Liberties Violator
GlobeNewswire
·
June 11, 2025
Washington, DC, June 11, 2025 (GLOBE NEWSWIRE) -- The Administrative State’s biggest abuser of civil liberties in 2024 was former Securities and Exchange Commission Chair Gary Gensler! After weeks of online voting for the New Civil Liberties Alliance’s …
INVESTOR DEADLINE MONDAY: Robbins Geller Rudman & Dowd Announces that Zenas BioPharma, Inc. (ZBIO) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
June 11, 2025
SAN DIEGO, June 11, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman …